Interpreting the association between cannabis use and increased risk for schizophrenia.

作者:

DOI: 10.31887/DCNS.2005.7.1/MWEISER

关键词:

摘要: Recent longitudinal studies from Sweden, the Netherlands, New Zealand, and Israel report that cannabis use during childhood adolescence doubles risk of later appearance psychosis or schizophrenia, These data have been interpreted as indicating has a causal effect along pathway to psychosis. In this paper, we will offer an alternative explanation these data. investigations patients with schizophrenia found increased density cannabinoid receptors in dorsolateral prefrontal cortex anterior cingulate cortex. Others reported higher levels endogenous cannabinoids blood cerebrospinal fluid patients; findings were independent possible use. Several genetic association between genes encoding receptor schizophrenia. Thus, might be pathology system is associated both rates for without being factor

参考文章(38)
Stanley Zammit, Peter Allebeck, Sven Andreasson, Ingvar Lundberg, Glyn Lewis, Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study BMJ. ,vol. 325, pp. 1199- 1199 ,(2002) , 10.1136/BMJ.325.7374.1199
Nicola De Marchi, Luciano De Petrocellis, Pierangelo Orlando, Fabiana Daniele, Filomena Fezza, Vincenzo Di Marzo, Endocannabinoid signalling in the blood of patients with schizophrenia Lipids in Health and Disease. ,vol. 2, pp. 5- 5 ,(2003) , 10.1186/1476-511X-2-5
Jim Van Os, Maarten Bak, M Hanssen, RV Bijl, R De Graaf, H Verdoux, Cannabis Use and Psychosis: A Longitudinal Population-based Study American Journal of Epidemiology. ,vol. 156, pp. 319- 327 ,(2002) , 10.1093/AJE/KWF043
Ronald C Kessler, Rosa M Crum, Lynn A Warner, Christopher B Nelson, John Schulenberg, James C Anthony, Lifetime Co-occurrence of DSM-III-R Alcohol Abuse and Dependence With Other Psychiatric Disorders in the National Comorbidity Survey Archives of General Psychiatry. ,vol. 54, pp. 313- 321 ,(1997) , 10.1001/ARCHPSYC.1997.01830160031005
J. A. Lieberman, B. J. Kinon, A. D. Loebel, Dopaminergic Mechanisms in Idiopathic and Drug-induced Psychoses Schizophrenia Bulletin. ,vol. 16, pp. 97- 110 ,(1990) , 10.1093/SCHBUL/16.1.97
Harith Swadi, Candace Bobier, Substance Use Disorder Comorbidity Among Inpatient Youths With Psychiatric Disorder Australian and New Zealand Journal of Psychiatry. ,vol. 37, pp. 294- 298 ,(2003) , 10.1046/J.1440-1614.2003.01180.X
J. Boydell, J. Van Os, M. Lambri, D. Castle, J. Allardyce, R. G. McCreadie, R. M. Murray, Incidence of schizophrenia in south-east London between 1965 and 1997 British Journal of Psychiatry. ,vol. 182, pp. 45- 49 ,(2003) , 10.1192/BJP.182.1.45
S. Leroy, N. Griffon, M.C. Bourdel, J.P. Olié, M.F. Poirier, M.O. Krebs, Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1. American Journal of Medical Genetics. ,vol. 105, pp. 749- 752 ,(2001) , 10.1002/AJMG.10038